Bill > HF383

This bill addresses the legal status of the controlled substance crystalline polymorph psilocybin (also known as COMP 360) in Iowa. The legislation proposes that upon approval by the United States Food and Drug Administration (FDA), this specific pharmaceutical composition will be immediately removed from Schedule I of controlled substances and rescheduled according to the FDA's recommendations and its listing in the federal Controlled Substances Act. Once rescheduled, the bill would make it legally permissible to prescribe, distribute, and market COMP 360 or any other FDA-approved trade name for this substance. This is a significant change that would effectively transition psilocybin from a strictly prohibited drug to a potentially medical-approved substance, contingent on FDA approval. The bill is set to take effect on July 1, 2025, and represents a progressive approach to the potential medical use of a substance that has traditionally been classified as a controlled substance.

Health and Social Services

Health And Human Services (House)

https://www.legis.iowa.gov/legislation/BillBook?ga=91&ba=HF383